NXTC

Latest SEC Filings & News for NXTC

1 most recent filing and news item mentioning NXTC. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/NXTC/news?limit=20"

Pull NXTC filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJun 1, 2026Positive

NextCure presents positive Phase 1 data for SIM0505 in gynecologic cancers

NextCure announced 55% objective response rate for SIM0505 in gynecologic cancers at ASCO 2026, with favorable safety in heavily pretreated patients. The data supports continued dose optimization and potential advancement toward pivotal trials for this CDH6-targeting antibody dru

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.